This review summarizes the design principles of three major metalloprotein-based nanomedicines, including native metalloproteins, engineered metalloproteins, and metal-protein hybrid nanostructures, with a focus on ferritin, transferrin, and heme/cytochrome proteins in the contexts of cancer therapy, imaging diagnostics, antimicrobial, and anti-resistance applications. Here, TF is linked to cancer.